ACCENTIA ASSUMPTION OF DEBT AND SECURITY AGREEMENTAssumption of Debt and Security Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • California
THIS ACCENTIA ASSUMPTION OF DEBT AND SECURITY AGREEMENT (this “Agreement”), dated as of December 31, 2003, is made and executed by and between ACCENTIA, INC., a Florida corporation (“Accentia”) and McKESSON CORPORATION, a Delaware corporation (“Secured Party” or “McKesson”) pursuant to that certain “Forbearance Agreement” dated as of December 9, 2003 by and among, McKesson, Accentia and Accent Rx and is based on the Recitals set forth in said Forbearance Agreement (all of which are incorporated herein by this reference), and also upon following facts and understandings:
FIRST AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS FIRST AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into as of February 20, 2003, by and between TEAMM Pharmaceuticals, Inc., a Florida corporation (the “Company”), and Martin G. Baum, an individual resident of Wake County, North Carolina (the “Employee”).
LOAN AGREEMENTEmployment Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Tennessee
THIS LOAN AGREEMENT (“Agreement”), dated as of the 9th day of August, 2002, is made and entered into on the terms and conditions hereinafter set forth, by and between TEAMM PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), and HARBINGER MEZZANINE PARTNERS, L.P., a Delaware limited partnership (“Lender”).
ACCENTIA, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
This Registration Rights Agreement (this “Agreement”) is made as of April 3, 2002, by and among Accentia, Inc., a Florida corporation (the “Company”), and Steven Arikian, M.D., John Doyle, Julian Casciano and Roman Casciano (the “Series B Stockholders”).
DISTRIBUTION AGREEMENTDistribution Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS DISTRIBUTION AGREEMENT, effective as of March 12, 2004, (the “Effective Date”) between Arius Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware, with its principal address of P.O. Box 14601, Research Triangle Park, NC 27709 (“Arius”), and TEAMM Pharmaceuticals, Inc., a Delaware corporation and subsidiary of Accentia, Inc., a Florida corporation, having its principal place of business at 3000 Aerial Center Parkway, Suite 110, Morrisville, North Carolina 27560 (“TEAMM”).
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Georgia
THIS MANUFACTURING AND SUPPLY AGREEMENT (the “Agreement”) is made and entered into this 6 day of June, 2003 (the “Effective Date”), by and between TEAMM PHARMACEUTICALS, INC. (“TEAMM”) and MIKART, INC. (“Mikart”). Mikart is a Georgia corporation with its principal place of business at 1750 Chattahoochee Avenue, Atlanta, Georgia 30318. TEAMM is a Florida corporation with its principal place of business at 3000 Aerial Center Parkway, Suite 110, Morrisville, North Carolina 27560.
LICENSE AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND ACCENTIA, INC.License Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
This License Agreement (this “Agreement”) effective as of April 12, 2004, by and between BioDelivery Sciences International, Inc., a Delaware corporation, having its principal place of business at 185 South Orange Avenue, Administrative Building No. 4, Newark, NJ 07103 (“BDSI”) and Accentia, Inc. having its principal place of business at 5310 Cypress Center Drive #101, Tampa, Florida 33609 (“ACCENTIA”) (collectively the “Parties”).
ACCENTIA, INC. Tampa, Florida 33609 April 3, 2002Accentia Biopharmaceuticals Inc • April 6th, 2005 • Pharmaceutical preparations • New York
This agreement sets forth our agreement on matters relating to your employment with Accentia, Inc. (the “Company”), as President of its subsidiary, The Analytica Group, Inc. (“Analytica”).
MASSACHUSETTS BIOTECHNOLOGY RESEARCH PARK Worcester, Massachusetts FOUR BIOTECH PARK SPACE LEASE WORCESTER BUSINESS DEVELOPMENT CORPORATION to UNISYN TECHNOLOGIES, INC.Space Lease • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS LEASE is made in Worcester, Massachusetts effective on the Date of Lease stated in Article 1 between the Landlord and the Tenant named in Article 1. In consideration of the Rent payable by Tenant and of the agreements to be performed and observed by Tenant, Landlord hereby leases the Premises to Tenant, and Tenant hereby takes the Premises from Landlord, subject to the provisions and for the term stated below:
DISTRIBUTION AGREEMENTDistribution Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THlS DISTRIBUTION AGREEMENT (“Agreement”) is dated June 15, 2004, by and among Argent Development Group, LLC, a California limited liability company (“Argent”), TEAMM Pharmaceuticals, Inc., a Florida corporation (“TEAMM”), and Accentia, Inc., a Florida corporation (“Accentia”). TEAMM is a wholly-owned subsidiary of Accentia.
REVOLVING CREDIT AGREEMENT between MISSOURI STATE BANK AND TRUST COMPANY, as Lender and ACCENTIA, INC., as Borrower Dated as of MARCH 30, 2004Revolving Credit Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Missouri
THIS REVOLVING CREDIT AGREEMENT (the “Agreement”) made and entered into as of this 30th day of March, 2004 by and between Accentia, Inc. (the “Borrower”), having an address of 5310 Cypress Center Drive, Tampa, Florida and Missouri State Bank and Trust Company, a Missouri state banking corporation (“Lender”), having an address of 12452 Olive Street Road, Creve Coeur, Missouri 63141.
ContractSupply Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
DISTRIBUTION AGREEMENTDistribution Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS DISTRIBUTION AGREEMENT (“Agreement”), is dated May 28, 2003, by and among Acheron Development Group, LLC, a California limited liability company with corporate address of P.O. Box 4531, Mountain View, CA 94040 (“Acheron”), TEAMM Pharmaceuticals, Inc., a Delaware corporation (“TEAMM”), and Accentia, Inc., a Florida corporation (“Accentia”). TEAMM is a wholly owned subsidiary of Accentia.
PRODUCT DEVELOPMENT AGREEMENTProduct Development Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS PRODUCT DEVELOPMENT AGREEMENT is made and entered into this 24th day of January, 2003 (the “Effective Date”) between Respirics, Inc., a Delaware corporation having an address at 6008 Triangle Drive, Suite 101, Raleigh, NC 27617 (hereinafter referred to as “Respirics”), and TEAMM Pharmaceuticals, a Delaware corporation and a wholly owned subsidiary of Accentia, Inc., a Florida corporation, having a primary address at 3000 Aerial Center Parkway, Suite 110, Morrisville, North Carolina 27560 (“TEAMM”).
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH LICENSE AGREEMENTLicense Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Minnesota
This license agreement (“Agreement”) is by and between Mayo Foundation For Medical Education And Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905-0001 (“MAYO”), and Accentia Specialty Biopharmaceuticals, Inc., Accentia Specialty Biopharmaceuticals, Inc. Suite 110, Aerial Center, Morrisville, NC 27560( “ACCENTIA”); each a “Party,” and collectively, “Parties.”
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Georgia
This AGREEMENT is made effective the 23rd day of August 2002, between TEAMM PHARMACEUTICALS, Inc. a Delaware corporation (“TEAMM”), 3000 Aerial Center Parkway, Suite 110, Morrisville, NC 27560, and KIEL LABORATORIES®, a Georgia corporation (“KIEL”), 2225 Centennial Drive, Gainesville, GA 30504.
DISTRIBUTION AGREEMENTDistribution Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS DISTRIBUTION AGREEMENT (“Agreement”), is dated May 23, 2003, by and among Ryan Pharmaceuticals, a Delaware corporation, with corporate address of 2493 Poinciana Dr., Weston, Florida 33327 (“Ryan Pharmaceuticals”), TEAMM Pharmaceuticals, Inc., a Delaware corporation (“TEAMM”), and Accentia, Inc., a Florida corporation (“Accentia”). TEAMM is a wholly owned subsidiary of Accentia.
LEASE AGREEMENT BETWEEN BAY VILLA DEVELOPERS, INC., AS GENERAL PARTNER FOR HYDE PARK PLAZA ASSOCIATES, LTD. (LANDLORD) AND ACCENTIA BIOPHARMACEUTICALS, INC. (TENANT)Lease Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
POST RESIDENTIAL RENTAL AGREEMENTPost Residential Rental Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
This Agreement made this 15 day of April, 2005 is between Post Apartment Homes, L.P., (hereinafter called “management” or Post”) and Accentia Inc.; James A. McNulty - (hereinafter called “resident” or “you” or “your”). Post rents to you, and you rent from Post, apartment no. 1026 (hereinafter called “apartment”) at Post Hyde Park, located at 502 S. Fremont Avenue, Tampa, Florida (hereinafter called the ‘premises’) under the following conditions:
DISTRIBUTION AGREEMENTDistribution Agreement • April 6th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS DISTRIBUTION AGREEMENT, effective as of January 24, 2003, between Respirics, Inc., a corporation organized and existing under the laws of Delaware, with its principal offices located at 6008 Triangle Drive, Suite 101, Raleigh, NC 27617 (“Respirics”), and TEAMM Pharmaceuticals, Inc., a Delaware corporation and subsidiary of Accentia, Inc., a Florida corporation; having its principal place of business at 3000 Aerial Center Parkway, Suite 110, Morrisville, North Carolina 27560 (“TEAMM”).
